Literature DB >> 16003756

Episode sensitivity in association with process indicators in the Finnish breast cancer screening program.

Tytti Sarkeala1, Matti Hakama, Irma Saarenmaa, Timo Hakulinen, Hakan Forsman, Ahti Anttila.   

Abstract

We assessed the episode sensitivity of the Finnish mammography program for women aged 50-59 (partly 60-64) years and explored associations between the episode sensitivity and the screening process indicators from 1991 to 1999. For the study period, data were available from 10 screening centers. Records of 721,000 screening visits were linked to the files of the nationwide Finnish Cancer Registry from 1991 to 2001 at an individual level. The rates of screen-detected and interval breast cancers were calculated at the first and at the subsequent screens. The episode sensitivity was determined by contrasting the incidence of interval cancers with the expected population incidence rate without screening (incidence method) and as a proportion of interval cancers out of all cancers detected (detection method). At the subsequent screens, the episode sensitivity determined by the incidence method was 54% and by the detection method 65%. The sensitivity 0-11 and 12-23 months after the screening was 70% and 38%, respectively. The episode sensitivity decreased toward the end of the study period and increased with age. The center-specific sensitivity increased 13% per 1% absolute increase in the recall rate. In general, our study provides further information on the effectiveness of screening programs. The sensitivity estimates were comparable with those from other European service screening programs. The variability in the episode sensitivity suggests potential for variations in the future screening outcome. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16003756     DOI: 10.1002/ijc.21310

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval.

Authors:  Jessica Chubak; Andrea N Burnett-Hartman; William E Barlow; Douglas A Corley; Jennifer M Croswell; Christine Neslund-Dudas; Anil Vachani; Michelle I Silver; Jasmin A Tiro; Aruna Kamineni
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-08-02       Impact factor: 4.090

2.  Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland.

Authors:  S Heinävaara; T Sarkeala; A Anttila
Journal:  Br J Cancer       Date:  2014-08-14       Impact factor: 7.640

3.  Association of symptoms and interval breast cancers in the mammography-screening programme: population-based matched cohort study.

Authors:  Deependra Singh; Joonas Miettinen; Stephen Duffy; Nea Malila; Janne Pitkäniemi; Ahti Anttila
Journal:  Br J Cancer       Date:  2018-11-07       Impact factor: 7.640

4.  Breast carcinoma detection modes and death in a female population in relation to population-based mammography screening.

Authors:  Tytti Sarkeala; Tapio Luostarinen; Tadeusz Dyba; Ahti Anttila
Journal:  Springerplus       Date:  2014-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.